Joshua Sieber received his B.S. degree in Chemistry from Penn State University with Honors in 2003. He then completed a PhD degree in Chemistry with Prof. James Morken at Boston College. His graduate work focused on the development and application of catalytic asymmetric diboration and conjugate allylation reactions. After receiving his PhD degree, he became an American Cancer Society postdoctoral fellow in the laboratories of Prof. Barry Trost at Stanford University where he completed the asymmetric total synthesis of Soraphen A and applied Pd-catalyzed asymmetric allylic alkylation reactions to natural product synthesis. He then accepted a position as a senior scientist in the process chemistry group at Boehringer Ingelheim Pharmaceuticals, Inc. in 2011 where he developed scalable processes towards new pharmaceuticals. After being promoted to Principal Scientist in 2016, he then became an assistant professor of chemistry at Virginia Commonwealth University in 2018.